secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001193125-23-187318
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Frequency Therapeutics to merge with Korro Bio in reverse merger; Korro valued at ~$325.6M
--------------------------------------------------------------------------------

- Korro Bio equity valued at ~$325.6M; Frequency equity based on net cash at closing.
- Concurrent PIPE financing of ~$117M from accredited investors.
- Combined company board: 4 from Korro, 1 from Frequency, 2 independent.
- ~98% of Korro stockholders and ~11.7% of Frequency stockholders support merger.
- Frequency stockholders to receive CVRs for potential proceeds from MS asset sale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523187318/0001193125-23-187318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523187318/d651936d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-187318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer